Screener
Cardiol Therapeutics CRDL Q3 2026 earnings
Reported November 12, 2026 · Before market open
EPS-$0.08Miss by $0.02
EPS estimate-$0.06
Next report
Date not yet announcedVersus estimates
Diluted EPS
FAQ
- When did Cardiol Therapeutics report Q3 2026 earnings?
- Cardiol Therapeutics (CRDL) reported Q3 2026 earnings on November 12, 2026 before market open.
- What were Cardiol Therapeutics's Q3 2026 revenue and EPS?
- Cardiol Therapeutics reported eps of $-0.08 for Q3 2026.
- Did Cardiol Therapeutics beat estimates in Q3 2026?
- EPS missed the consensus estimate of $-0.06 by $0.02.
- How did Cardiol Therapeutics's Q3 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 11.1% from $-0.09.
